When you make something that could be the difference between life and death, (FR), development will always take time.
However, they are making $M sales in their chem, even if it isn't for FR, so it isn't a dud.
I compare AJX to EDE. Both have developed a potentially world leading implementation of a product. Both were initially priced on the potential, AKX was first to enter the Sales or Die downward pattern, (where teh coy transitions from development to sales), EDE has just entered it. AJX are making significant sales, EDE not just yet. Pricing now reflects that.
AJX Price at posting:
30.5¢ Sentiment: Buy Disclosure: Held
